Diabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA.
J Nutr. 2022 Aug 9;152(8):1872-1885. doi: 10.1093/jn/nxac031.
Growth abnormalities in childhood have been related to later cardiometabolic risks, but little is known about these associations in populations at high risk of type 2 diabetes.
We examined the associations of patterns of growth, including weight and height at ages 1-59 months, with cardiometabolic risk factors at ages 5-16 years.
We linked anthropometric data collected at ages 1-59 months to cardiometabolic data obtained from a longitudinal study in a southwestern American Indian population at high risk of diabetes. Analyses included 701 children with ≥1 follow-up examination at ages 5-16 years. We derived age- and sex-specific weight-for-height z-scores (WHZ) and height-for-age z-scores (HAZ) at ages 1-59 months. We selected the highest observed WHZ and the lowest observed HAZ at ages 1-59 months and analyzed associations of z-scores and categories of WHZ and HAZ with cardiometabolic outcomes at ages 5-16 years. We used linear mixed-effects models to account for repeated measures.
Overweight/obesity (WHZ >2) at ages 1-59 months was significantly associated with increased BMI, fasting and 2-hour postload plasma glucose, fasting and 2-hour insulin, triglycerides, systolic blood pressure, diastolic blood pressure, and decreased HDL cholesterol at ages 5-16 years relative to normal weight (WHZ ≤1). For example, at ages 5-9 years, 2-hour glucose was 10.4 mg/dL higher (95% CI: 5.6-15.3 mg/dL) and fasting insulin was 4.29 μU/mL higher (95% CI: 2.96-5.71 μU/mL) in those with overweight/obesity in early childhood. Associations were attenuated and no longer significant when adjusted for concurrent BMI. A low height-for-age (HAZ < -2) at ages 1-59 months was associated with 5.37 mg/dL lower HDL (95% CI: 2.57-8.17 mg/dL) and 27.5 μU/mL higher 2-hour insulin (95% CI: 3.41-57.6 μU/mL) at ages 10-16 years relative to an HAZ ≥0.
In this American Indian population, findings suggest a strong contribution of overweight/obesity in early childhood to cardiometabolic risks in later childhood and adolescence, mediated through persistent overweight/obesity into later ages. Findings also suggest potential adverse effects of low height-for-age, which require confirmation.
儿童期生长异常与日后的心血管代谢风险相关,但在 2 型糖尿病高危人群中,人们对这些关联知之甚少。
我们检测了儿童在 1-59 月龄时的生长模式(包括体重和身高)与 5-16 岁时心血管代谢风险因素之间的关联。
我们将在西南美国印第安人糖尿病高危人群中进行的一项纵向研究中收集的 1-59 月龄时的人体测量数据与心血管代谢数据进行了关联分析。分析纳入了 701 名至少在 5-16 岁时有 1 次以上随访检查的儿童。我们得出了在 1-59 月龄时年龄和性别特异性的体重身高 z 评分(WHZ)和身高年龄 z 评分(HAZ)。我们选择了在 1-59 月龄时观察到的最高 WHZ 和最低 HAZ,并分析了 z 评分和 WHZ 和 HAZ 类别与 5-16 岁时心血管代谢结果的关联。我们使用线性混合效应模型来解释重复测量。
与正常体重(WHZ≤1)相比,1-59 月龄时超重/肥胖(WHZ>2)与 BMI、空腹和 2 小时餐后血糖、空腹和 2 小时胰岛素、甘油三酯、收缩压、舒张压和高密度脂蛋白胆固醇降低相关。例如,在 5-9 岁时,早期儿童期超重/肥胖者的 2 小时血糖升高 10.4mg/dL(95%CI:5.6-15.3mg/dL),空腹胰岛素升高 4.29μU/mL(95%CI:2.96-5.71μU/mL)。当调整为同时的 BMI 时,这些关联减弱且不再显著。1-59 月龄时身高较低(HAZ<-2)与 HDL 降低 5.37mg/dL(95%CI:2.57-8.17mg/dL)和 2 小时胰岛素升高 27.5μU/mL(95%CI:3.41-57.6μU/mL)相关。
在这个美国印第安人群中,研究结果表明,儿童早期超重/肥胖对儿童后期和青少年期的心血管代谢风险有很强的影响,这是通过持续超重/肥胖到后期年龄来介导的。研究结果还表明,身高较低可能会产生潜在的不良影响,但需要进一步证实。